Epilepsy: Venture Philanthropy Pays Off

March 9, 2009 - PRLog -- Epilepsy Therapy Project, a nonprofit organization that supports inventors and entrepreneurs to develop new therapies the treatment of epilepsy, is proud to report the successful milestone for ganaxolone, a new epilepsy therapy.

ETP was an early supporter of Marinus Pharmaceuticals, Inc., providing seed funds and introductions that helped the company engage venture capital groups to provide the $30 million needed to reach this stage.

Our seed funding is an example of ETP’s venture philanthropy program: Our goal is to assist start-up companies to move to the next step leading toward a new therapy for epilepsy. Since inception, ETP has provided 33 grants for specific, short-term project, one matching grant, and three seed-stage investments to support start-up companies.

Visit us at www.epilepsy.com/epilepsy_therapy_project

# # #

Epilepsy Therapy Project, the sponsor of epilepsy.com , is a non-profit organization whose mission is to advance new treatments for people living with epilepsy. ETP helps to fast-track great ideas scientists develop to reach people as fast as possible.